Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2006

DSM Biologics Provides Manufacturing Services to Argenes

  • DSM Biologics and Argenes signed a biopharmaceutical manufacturing agreement. Under the terms of the agreement, DSM Biologics will provide Argenes with full process development services, analytical development services, and manufacturing batches for Argenes’ Anti-Fas IgM Mab.

    Argenes’ Anti-FAS IgM Mab is being developed as an antirheumatic agent. The services will be provided out of DSM Biologics’ manufacturing facility in Groningen, The Netherlands.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »